MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework May 31, 2009
"MedTrust Online continues to provide answers to the most difficult problems in cancer care today," stated former CEO of ILEX Oncology, Inc., Richard Love, a MedTrust Online Board Member. "As use of the portal grows, MedTrust Online will have as important an impact on treating patients with cancer as the new targeted therapies being developed today.". (PR Newswire)
Med-tech players get connected Apr 20, 2009
3 million in July 2006; and Lee with ILEX Oncology Inc., a local cancer drug developer acquired by Cambridge, Mass. -based in a stock-for-stock transaction valued at $1 billion in December 2004. (San Antonio Business Journal, TX)
Genzyme acquires rights to Campath Apr 1, 2009
Genzyme acquired Campath when it bought Ilex Oncology Inc. of San Antonio in 2004, but shares marketing and distribution rights with Bayer HealthCare, a subsidiary of Bayer AG of Germany. In addition, Genzyme is buying two established cancer drugs from Bayer, Fludara and Leukine. (Boston Globe)
Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth Feb 13, 2009
D has been appointed President and COO. Dr. Rice has over 25 years of oncology drug development experience in the biopharmaceutical industry including research, preclinical and clinical trials as well as extensive experience in licensing, partnerships and M&A. He was the CEO and Founder of Bridge Laboratories (a large and pioneering international drug development contract research organization); Vice President of Biosciences at SRI International (management of 180 scientists and staff), Vice... (PR Newswire)
